Clear Metabolic

Archives
Log in
April 26, 2026

ClearMetabolic: GLP-1 and Pancreatitis Risk: Separating...

GLP-1 and Pancreatitis Risk: Separating Fact From Fear, GLP-1 and Gut Health: What Happens to Your Microbiome.

ClearMetabolic

GLP-1 news, pricing changes, and new guides. Week of April 26, 2026.

This Week in 30 Seconds

GLP-1 and Pancreatitis Risk GLP-1 pancreatitis risk
GLP-1 and Gut Health How GLP-1 medications

Featured

GLP-1 and Pancreatitis Risk: Separating Fact From Fear

GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) carry a pancreatitis warning on their FDA labels, but clinical trial rates are low. In SURMOUNT-1, acute pancreatitis occurred in less than 0.1% of tirzepatide users.

Read the full article

Also This Week

GLP-1 and Gut Health: What Happens to Your Microbiome

How GLP-1 medications like Mounjaro and Ozempic affect your gut microbiome. Research on semaglutide, tirzepatide, and di...

Read the full article →

That's it for this week. If you have questions about GLP-1 medications, reply to this email.

Ash

clearmetabolic.com

90 providers • 58 reviews • 63 guides • 11 medications • 6 tools • clearmetabolic.com

Unsubscribe

Don't miss what's next. Subscribe to Clear Metabolic:
Powered by Buttondown, the easiest way to start and grow your newsletter.